Koji Matsumoto

No ORCID on file · 7 papers in corpus · active 2000-2017

Study types

  • article 4
  • other 2
  • review 1

Condition tags

  • endometriosis 4
  • mesh:D004715 2
  • endometrioma 2
article 2017
article 2017
article 2017
article 2016

Dienogest is a novel synthesized progestin used for treatment of endometriosis. This is the first case report describing a therapeutic effect of dienogest on a gynecologic malignancy. The patient was a 44-year-old woman with advanced adenos…

other 2016
Cancer imaging : the official publication of the International Cancer Imaging Society ·doi:10.1186/s40644-016-0061-9

BACKGROUND: Primary epithelial ovarian carcinoma is sub-classified into serous, mucinous, endometrioid and clear cell subtypes. Neoadjuvant chemotherapy has become an alternative treatment option past several years, as serous carcinoma, the…

other 2013
SpringerPlus ·doi:10.1186/2193-1801-2-618

Dienogest is a novel synthesized progestin used for treatment of endometriosis. This is the first case report describing a therapeutic effect of dienogest on a gynecologic malignancy. The patient was a 44-year-old woman with advanced adenos…

review 2000
Gynecologic and obstetric investigation ·doi:10.1159/000052873

Endometriosis may be the precursor of clear cell or endometrioid ovarian cancer. In this review, we focus on the prevalence of endometriosis in ovarian cancer and related clinical and epidemiological issues. According to 15 published report…